Jiri Smejkal | Access & Value Head PDT
Takeda

Jiri Smejkal is the International Business Unit Head of Access & Value for Plasma Derived Therapies (PDT), leading global strategy to ensure broad, rapid patient access to innovative treatments across global markets. An executive with over a decade of leadership, GMs' regional roles and global access global roles, Jiri brings deep expertise in access, pricing and tender excellence, creating value-based strategies for market access of rare diseases and specialty pharmaceuticals. With extensive experience navigating complex market and industry environments, Jiri offers unique insight into the broader impact on patients and society—while staying at the forefront of healthcare innovation.